| Identification | |
|---|---|
| Name | K-252a |
| Accession Number | DB02152 (EXPT01983) |
| Type | small molecule |
| Description | Not Available |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 467.4727 |
| Groups | experimental |
| Monoisotopic Weight | 467.148120797 |
| Pharmacology | |
| Indication | Not Available |
| Mechanism of action | Not Available |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms | Not Available |
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Hepatocyte growth factor receptor | |
|---|---|
| Name | Hepatocyte growth factor receptor |
| Gene Name | MET |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | 1.8326 |
| Dual specificity mitogen-activated protein kinase kinase 1 | |
| Name | Dual specificity mitogen-activated protein kinase kinase 1 |
| Gene Name | MAP2K1 |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | 1.6301 |
| Id | Partner name | Gene Name | Score |
|---|---|---|---|
| 4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0368 |
| 4177 | Proto-oncogene tyrosine-protein kinase receptor ret | RET | 0.0357 |
| 407 | Vascular endothelial growth factor receptor 2 | KDR | 0.0289 |
| 6893 | Calcium/calmodulin-dependent protein kinase type II gamma chain | CAMK2G | 0.0284 |
| 6824 | Tyrosine-protein kinase Lyn | LYN | 0.0262 |
| 2599 | Tyrosine-protein kinase HCK | HCK | 0.0247 |
| 4924 | Cytochrome P450 2C8 | CYP2C8 | 0.0237 |
| 17 | Proto-oncogene tyrosine-protein kinase ABL1 | ABL1 | 0.0177 |
| 933 | Proto-oncogene tyrosine-protein kinase Src | SRC | 0.0152 |
| 4757 | Cytochrome P450 2C9 | CYP2C9 | 0.0125 |
| 2240 | Cell division protein kinase 2 | CDK2 | 0.0122 |
| 1588 | Multidrug resistance protein 1 | ABCB1 | 0.0074 |